Home LiteratureArticle Details
PMID: 12704343 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

IL-13 receptors and signaling pathways: an evolving web.

The Journal of allergy and clinical immunology ·Vol. 111 ·No. 4 ·2003-04-00 ·Pages 677-90; quiz 691

Hershey GK

Abstract

IL-13 is an immunoregulatory cytokine secreted predominantly by activated T(H)2 cells. Over the past several years, it has become evident that IL-13 is a key mediator in the pathogenesis of allergic inflammation. IL-13 shares many functional properties with IL-4, stemming from the fact that they share a common receptor subunit, the alpha subunit of the IL-4 receptor (IL-4Ralpha). Characterization of IL-13-deficient mice, IL-4-deficient mice, and IL-4 receptor alpha-deficient (IL-4Ralpha(-/-)) mice have demonstrated nonredundant roles for IL-13. IL-13 mediates its effects by interacting with a complex receptor system comprised of IL-4Ralpha and two IL-13 binding proteins, IL-13Ralpha1 and IL-13Ralpha2. IL-13 receptors are expressed on human B cells, basophils, eosinophils, mast cells, endothelial cells, fibroblasts, monocytes, macrophages, respiratory epithelial cells, and smooth muscle cells. However, functional IL-13 receptors have not been demonstrated on human or mouse T cells. Thus unlike IL-4, IL-13 does not appear to be important in the initial differentiation of CD4 T cells into T(H)2-type cells but rather appears to be important in the effector phase of allergic inflammation. This is further supported by many in vivo observations, including that administration of IL-13 resulted in allergic inflammation, tissue-specific overexpression of IL-13 in the lungs of transgenic mice resulted in airway inflammation and mucus hypersecretion, IL-13 blockade abolished allergic inflammation independently of IL-4, and IL-13 appears to be more important than IL-4 in mucus hypersecretion. Given the importance of IL-13 as an effector molecule, regulation at the level of its receptors might be an important mechanism of modulating IL-13 responses and thus propagation of the allergic response. Accordingly, IL-13 is an attractive, novel therapeutic target for pharmacologic intervention in allergic disorders. This review will summarize the current understanding of the IL-13 receptors and signaling pathways, emphasizing recent observations.

MeSH Terms
Animals Cytokines/physiology Humans Interleukin-13/chemistry,genetics,physiology Interleukin-13 Receptor alpha1 Subunit Janus Kinase 1 Protein-Tyrosine Kinases/physiology Receptors, Interleukin/physiology Receptors, Interleukin-13 Receptors, Interleukin-4/physiology STAT6 Transcription Factor Signal Transduction/physiology Trans-Activators/physiology src Homology Domains
Chemicals
Cytokines IL13RA1 protein, human Il13ra1 protein, mouse Interleukin-13 Interleukin-13 Receptor alpha1 Subunit Receptors, Interleukin Receptors, Interleukin-13 Receptors, Interleukin-4 STAT6 Transcription Factor STAT6 protein, human Trans-Activators Protein-Tyrosine Kinases JAK1 protein, human Jak1 protein, mouse Janus Kinase 1
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Hershey Gurjit K Khurana
Division of Allergy, and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
Article Info
Journal
The Journal of allergy and clinical immunology
Abbr.
J Allergy Clin Immunol
ISSN
0091-6749
Published
2003-04-00
Pages
677-90; quiz 691
Language
English
Region
United States
NLM ID
1275002
Subset
IM
Grants
NIAID NIH HHS · R01AI46652-01A1 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]